key: cord-1000429-rwer0to9
authors: Bhattarai, Nisha; Baral, Prabin; Gerstman, Bernard S.; Chapagain, Prem P.
title: Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351
date: 2021-06-10
journal: J Phys Chem B
DOI: 10.1021/acs.jpcb.1c01626
sha: 373d2536c14096f648c13d948983a4587b139993
doc_id: 1000429
cord_uid: rwer0to9

[Image: see text] The novel coronavirus (SARS-CoV-2) pandemic that started in late 2019 is responsible for hundreds of millions of cases worldwide and millions of fatalities. Though vaccines are available, the virus is mutating to form new strains among which are the variants B.1.1.7 and B.1.351 that demonstrate increased transmissivity and infectivity. In this study, we performed molecular dynamics simulations to explore the role of the mutations in the interaction of the virus spike protein receptor binding domain (RBD) with the host receptor ACE2. We find that the hydrogen bond networks are rearranged in the variants and also that new hydrogen bonds are established between the RBD and ACE2 as a result of mutations. We investigated three variants: the wild-type (WT), B.1.1.7, and B.1.351. We find that the B.1.351 variant (also known as 501Y.V2) shows larger flexibility in the RBD loop segment involving residue K484, yet the RBD–ACE2 complex shows higher stability. Mutations that allow a more flexible interface that can result in a more stable complex may be a factor contributing to the increased infectivity of the mutated variants.

The highly contagious severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a form of severe acute respiratory syndrome coronavirus (SARS) that had an outbreak in China in 2003 and causes the COVID-19 disease in a number of animal species including humans. 1−3 The first case of SARS-CoV-2 was detected in December 2019 in Wuhan, China, and a pandemic was declared in March 2020 due to its worldwide transmission. A person contracting this disease can have symptoms including fever, dry cough, headache, breathing difficulties, and pneumonia. 2−4 In January 2021, the number of SARS-CoV-2 cases surpassed 100 million worldwide with over 2 million deaths. Vaccines produced by Pfizer/BioNTech and Moderna have been authorized for emergency use in the United States after demonstrating efficacy in clinical trials. 5 Despite the progress in vaccine administration, emergence of mutated variants is raising concerns about vaccine efficacies. Notably, the viruses that emerged in the United Kingdom (B.1.1.7 lineage) and separately in South Africa (B.1.351 lineage, also known as 501Y.V2) are reported to increase the transmission of the virus and host immune evasion. 6, 7 In the spike protein alone, the B.1.1.7 variant has amino acid deletions at H69, V70, and Y144 and mutations N501Y, A570D, P681H, T716I, S982A, and D1118H, while the South African variant has mutations L18F, D80A, D215G, R246I, K417N, E484K, N501Y, and A701V. 8 The N501Y mutation at the receptor binding domain (RBD) that directly interacts with the human receptor ACE2, as shown in Figure 1 , is found to be common in both of these mutants and is assumed to increase virus infectivity and transmittivity. 9 In the South African variant, mutations in the RBD (K417N, E484K, and N501Y) are thought to have functional significance. 10 The B.1.1.7 variant is reported to have a 71% higher transmission rate than the other variants. 11 The full significance of the B.1.351 variant is still unclear, and it is assumed that this lineage could be associated with increased transmissibility 10 and render current vaccines significantly less effective. 12 The occurrence of mutated variants with increased rates of virus transmission and immune evasion has raised concern about the necessity of modifying existing vaccines and treatments. 12, 13 Guidance for these interventions can benefit from an understanding of changes in the molecular mechanisms of infection as a result of the mutations, which is also essential for understanding the enhanced virulence of the mutated variants. Although some of the studies have been performed with these variants, 14 the details of amino acids that play crucial roles at the RBD−ACE2 interface yet remain unexplored. In this study, we investigated the changes in molecular bonding patterns between the spike protein-mutated RBD and the host ACE2 for the B.1.1.7 and B.1.351 variants compared to that of the wild-type (WT). We find that the mutations have significant effects by changing the amino acids responsible for hydrogen bonding between the RBD and ACE2.

2.1. System Preparation. A fully glycosylated SARS-CoV-2 spike trimer in which one of the receptor binding domains is facing upwards and complexed with ACE2 was retrieved from the archives of the CHARMM-GUI 15,16 COVID-19 repository (PDB ID 6VSB_6VW1). 17−19 This wild-type (WT) structure contains modeled glycan chains at the glycosylated sites and has the missing residues filled with GalaxyFill. 20, 21 The mutations or deletions were then introduced to this WT structure using CHARMM-GUI. 16 We prepared a total of nine independent systems: the spike trimer complexed with ACE2, spike RBD− ACE2 complex, and RBD-only system for each of WT, B.1.1.7, and B.1.351 variants. Residues 1−1146 were considered in the spike trimer structure and 19−614 in the ACE2 domain. Similarly, the RBD residues 330−530 were used in the RBDonly as well as for the RBD−ACE2 complex systems, and residues 19−614 were used in the ACE2 domain. All nine systems were set up using the CHARMM-GUI Solution Builder tool with standard parameters, including a physiological salt concentration of 0.15 M KCl.

2.2. Molecular Dynamics Simulations. All-atom, explicit solvent molecular dynamics (MD) simulations were performed using the NAMD 2.13 simulation package 22 with the Charmm36m force field. 23, 24 The covalent bonds involving hydrogen atoms were constrained by using the SHAKE algorithm, 25 and the pressure was controlled using the Nose− Hoover Langevin piston method 26 with a piston decay of 25 fs and a period of 50 fs. The particle mesh Ewald method 27 was used to calculate the long-range ionic interactions, and the temperature was controlled by using the Langevin temperature coupling with a friction coefficient of 1 ps −1 . Minimization and equilibration were performed with NVT (constant volume and temperature) conditions, and the production runs were performed under NPT (constant pressure and temperature) conditions at 303 K using 2 fs time steps. The RBD-only systems were run for 600 ns each, and the RBD−ACE2 systems were run for 200 ns each. Additional replicas of RBD-only systems were run for 300 ns. For all larger systems of spike protein trimer− ACE2 complexes (∼900 000 atoms), the production runs were limited to 50 ns each, which should be sufficient for the sidechain relaxations upon mutation but not for large-scale conformational changes. Visualization and rendering of trajectories were done with visual molecular dynamics (VMD). 28 2.3. Dynamical Network Analysis. We used the Network Plugin in VMD 29, 30 for dynamical network analysis calculations. Carma 31 and Catdcd 30 were used to calculate the covariance and correlations between interfacial amino acid pairs during an MD trajectory. To generate the amino acid community network, gncommunities 29 was employed. Using the Girvan−Newman algorithm, the time-averaged connectivity of the nodes was determined and the shortest path between the nodes for connections was also identified. 32 2.4. Principal Component Analysis. The principal component analysis (PCA) of the Bio3D 33 software package was used to study the coordinated motions of amino acids and to understand the conformational motions of the atoms in all three systems. First, least-squares fitting is used to remove the translational and rotational motions of the proteins during the MD trajectory and the remaining motion of the protein atoms is analyzed.

The spike protein of the B. Figure S2a ). In Figure S2b , we plotted the acceptor− donor distances between the important hydrogen-bond-forming residues for all three variants. The hydrogen bond Y473−Y489 remains intact for all three variants, whereas other hydrogen bonds fluctuate and differ. We superimposed five conformations of each variant from the last 500 ns (one conformation every 100 ns) and are displayed in Figure 2d Figures 2e,f and  S2 and Movie S1). This observation is reproduced in the 300 ns replica run, which shows even clearer differences in the flexibility ( Figure S3b,d) . A flexible loop in B.1.351 may allow the RBD to bind with ACE2 more easily by induced fit mechanism. To investigate the binding with ACE2, we further explored the interactions in the RBD−ACE2 complexes.

To understand the differences in the ACE2 binding, we explored the dynamics of the RBD−ACE2 complexes for all three variants. The analyses of the interaction pattern between the viral spike protein RBD and the receptor protein ACE2 from the 200 ns of MD simulations show that the B.1.1.7 and B.1.351 mutations have a significant impact on the association of residues in the interfacial region. Figure 3 shows the conformations of each system at 100 ns. The mutated residues are labeled, and the residues across the interface interacting within 3.5 Å of each other are highlighted.

To determine how the B.1.1.7 and B.1.351 variants differ from the WT in RBD−ACE2 bonding, we calculated the number of hydrogen bonds formed during the last 100 ns of the MD simulations. The residue pairs that have significant interaction between the RBD and the ACE2 are identified from the hydrogen bond occupancy rate for each residue pair. Some of the residues contributing to the formation of hydrogen bonds in the RBD−ACE2 complex for the WT, B.1.1.7, and B.1.351 variants are highlighted in Figure 3 . Table S2 . These calculations show that the binding affinities are essentially the same in these variants, suggesting that the complexes have similar stabilities. To further The Journal of Physical Chemistry B pubs.acs.org/JPCB Article explore the interprotein interactions and the stability of complexes, we performed dynamical network analysis.

Motions in the Variants. The bonding interactions described above between the viral RBD and the host ACE2 are crucial in stabilizing the complex. The relative stability of the RBD−ACE2 complex for the different variants can be elucidated by investigating the conformational flexibility between the RBD and ACE2. We examined this by using a dynamical network analysis method. Dynamical network analysis quantifies connection networks and communities by examining correlated motions in proteins and nucleic acids. 29,36−38 It generates detailed information on the connections of amino acids in the form of communities and gives information about how strongly the amino acids are connected and how much their motion is correlated. Figure 5 shows various amino acid communities in the dynamic network obtained from the last 100 ns of the MD simulation. Amino acids are represented as nodes centered at the C α , and the correlated motion between the amino acids is represented by the weighted edge (bar) between the nodes. The thickness of the edges represents the strength of the connections between the nodes. For nodes to be in the same community, they need to have a connection for more than 80% of the time. 29 Figure 5a−c shows various dynamic network communities obtained for all variants, with each community colored differently. To visualize the interprotein interactions between the RBD and the ACE2, the communities that span over both of these proteins are highlighted in the expanded view of the interfacial region shown in Figure 5d −f. Amino acids present within the same community have highly correlated motions. This means that if a community spreads over the interface to include both the RBD and ACE2, the flexibility of the RBD with respect to the ACE2 is reduced. The amino acids in the RBD and ACE2 that compose each community and their interprotein connections are given in Table S1 . The decrease in interfacial flexibility is notable for the B.1.351 variant, which has more and stronger interprotein connections (larger edge weights), compared to that in the WT and the B. Figure S4 shows the range of motion from the principal components (PCs) 1 and 2 for each amino acid for the WT, B.1.17, and B.1.351 variants. The blurrier RBD in Figure S4a implies a greater range of motion for the WT, compared to that of the B.1.351 variant in Figure S4c . The conformational motion of the first three PCA eigenvectors PC1, PC2, and PC3 was projected onto 2D subspaces, as shown in Figure S4d −f. The conformational state of the system in each MD frame is represented by the blue and red dots. These distributions show that the WT complex has a greater conformational range than that of the mutated systems, with the B.1.351 showing more clustered PC1/PC2 and PC1/PC3. These findings are consistent with the results of the hydrogen bond and dynamical network analyses.

The SARS-CoV-2 spike protein is the major surface protein of the virion that is primarily responsible for the virus's ability to enter the human host through the ACE2 receptor. The interfacial region of the spike RBD−ACE2 complex plays a major role in the binding of the virus to the host cell. The emergence of mutated variants in the B. The Journal of Physical Chemistry B pubs.acs.org/JPCB Article vaccine efficacy for a variant is difficult to address but these studies provide information on the molecular interactions of RBD−ACE2 complexes in different variants, and it can be important for understanding the molecular mechanism of the virus entry into the cell and designing therapeutic interventions. Further studies are needed to understand the full scope of the effects resulting from the mutations or deletions. For example, the mutations may affect trimer formation or trimer stability. In fact, it is recently shown that the D614G mutation enhances the spike protein trimer stability and prevents premature release of S1 subunit. 39 It will be useful to know how the mutations affect the springing up of the RBD from the closed conformation that is shielded with glycans 40, 41 or how the mutations in the rest of the spike, including the ones in the furin cleavage site, 42 

A new coronavirus associated with human respiratory disease in China

Origin and evolution of pathogenic coronaviruses

SARS-CoV-2 vaccines in development

Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70

Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein

Covid-19: New coronavirus variant is identified in UK

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South

Covid-19: What have we learnt about the new variant in the UK?

How to redesign COVID vaccines so they protect against variants

Nussenzweig, M. C. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants bioRxiv 2021

Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y. V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant bioRxiv 2021

Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane

CHARMM-GUI: a web-based graphical user interface for CHARMM

Structural basis of receptor recognition by SARS-CoV-2

The protein data bank

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

The FALC-Loop web server for protein loop modeling

GalaxyTBM: template-based modeling by building a reliable core and refining unreliable local regions

Scalable molecular dynamics with NAMD

CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data

Force field development and simulations of intrinsically disordered proteins

Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes

A simulation study used to design the sequential monitoring plan for a clinical trial

A smooth particle mesh Ewald method

VMD: visual molecular dynamics

Dynamical networks in tRNA:protein complexes

NetworkView: 3D display and analysis of protein.RNA interaction networks

Software news and updates. Carma: a molecular dynamics analysis program

Community structure in social and biological networks

Bio3d: an R package for the comparative analysis of protein structures

Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions

PRODIGY: a web server for predicting the binding affinity of protein-protein complexes

The Role of the Interdomain Interactions on RfaH Dynamics and Conformational Transformation

Dynamic architecture of a protein kinase

Experimental and computational determination of tRNA dynamics

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Controlling the SARS-CoV-2 spike glycoprotein conformation

The SARS-CoV-2 spike protein: balancing stability and infectivity

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin

The authors declare no competing financial interest. 

The Journal of Physical Chemistry B pubs.acs.org/JPCB Article